ID | 65505 |
フルテキストURL | |
著者 |
Matsumoto, Yoshinori
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
researchmap
Rottapel, Robert
|
抄録 | Modification of proteins by ADP-ribose (PARsylation) is catalyzed by the poly(ADP-ribose) polymerase (PARP) family of enzymes exemplified by PARP1, which controls chromatin organization and DNA repair. Additionally, PARsylation induces ubiquitylation and proteasomal degradation of its substrates because PARsylation creates a recognition site for E3-ubiquitin ligase. The steady-state levels of the adaptor protein SH3-domain binding protein 2 (3BP2) is negatively regulated by tankyrase (PARP5), which coordinates ubiquitylation of 3BP2 by the E3-ligase ring finger protein 146 (RNF146). 3BP2 missense mutations uncouple 3BP2 from tankyrase-mediated negative regulation and cause Cherubism, an autosomal dominant autoinflammatory disorder associated with craniofacial dysmorphia. In this review, we summarize the diverse biological processes, including bone dynamics, metabolism, and Toll-like receptor (TLR) signaling controlled by tankyrase-mediated PARsylation of 3BP2, and highlight the therapeutic potential of this pathway.
|
キーワード | PARsylation
ubiquitylation
proteasomal degradation
Cherubism
tankyrase
PARPs
|
発行日 | 2023-05
|
出版物タイトル |
Trends in Molecular Medicine
|
巻 | 29巻
|
号 | 5号
|
出版者 | Elsevier BV
|
開始ページ | 390
|
終了ページ | 405
|
ISSN | 1471-4914
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2023 The Authors.
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.1016/j.molmed.2023.02.001
|
ライセンス | http://creativecommons.org/licenses/by/4.0/
|